MDM4 (MDMX) and its Transcript Variants
- PMID: 19721810
- PMCID: PMC2699833
- DOI: 10.2174/138920209787581280
MDM4 (MDMX) and its Transcript Variants
Abstract
MDM family proteins are crucial regulators of the oncosuppressor p53. Alterations of their gene status, mainly amplification events, have been frequently observed in human tumors.MDM4 is one of the two members of the MDM family. The human gene is located on chromosome 1 at q32-33 and codes for a protein of 490aa. In analogy to MDM2, besides the full-length mRNA several transcript variants of MDM4 have been identified. Almost all variants thus far described derive from a splicing process, both through canonical and aberrant splicing events. Some of these variants are expressed in normal tissues, others have been observed only in tumor samples. The presence of these variants may be considered a fine tuning of the function of the full-length protein, especially in normal cells. In tumor cells, some variants show oncogenic properties.This review summarizes all the different MDM4 splicing forms thus far described and their role in the regulation of the wild type protein function in normal and tumor cells. In addition, a description of the full-length protein structure with all known interacting proteins thus far identified and a comparison of the MDM4 variant structure with that of full-length protein are presented. Finally, a parallel between MDM4 and MDM2 variants is discussed.
Keywords: MDM2.; MDM4; MDM4-211; MDM4-S; p53; transcript variants.
Figures


Similar articles
-
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties.J Mol Med (Berl). 2008 May;86(5):585-96. doi: 10.1007/s00109-008-0322-6. Epub 2008 Mar 12. J Mol Med (Berl). 2008. PMID: 18335186 Free PMC article.
-
Regulation of MDM4 (MDMX) function by p76(MDM2): a new facet in the control of p53 activity.Oncogene. 2010 Nov 4;29(44):5935-45. doi: 10.1038/onc.2010.324. Epub 2010 Aug 9. Oncogene. 2010. PMID: 20697359
-
Identification and expression of a novel MDM4 splice variant in human glioma.Brain Res. 2013 Nov 6;1537:260-6. doi: 10.1016/j.brainres.2013.07.054. Epub 2013 Aug 30. Brain Res. 2013. PMID: 23994448
-
Targeting MDM4 Splicing in Cancers.Genes (Basel). 2017 Feb 20;8(2):82. doi: 10.3390/genes8020082. Genes (Basel). 2017. PMID: 28230750 Free PMC article. Review.
-
MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.Am J Cancer Res. 2021 Dec 15;11(12):5864-5880. eCollection 2021. Am J Cancer Res. 2021. PMID: 35018230 Free PMC article. Review.
Cited by
-
Genetic and Epigenetic Discoveries in Human Retinoblastoma.Crit Rev Oncog. 2015;20(3-4):217-25. doi: 10.1615/critrevoncog.2015013711. Crit Rev Oncog. 2015. PMID: 26349417 Free PMC article. Review.
-
TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma.Cell Cycle. 2021 Mar-Mar;20(5-6):603-615. doi: 10.1080/15384101.2021.1892321. Epub 2021 Mar 8. Cell Cycle. 2021. PMID: 33678118 Free PMC article.
-
S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia.Cancer Sci. 2012 Dec;103(12):2056-63. doi: 10.1111/cas.12008. Epub 2012 Oct 10. Cancer Sci. 2012. PMID: 22937789 Free PMC article.
-
Loss of TAF8 causes TFIID dysfunction and p53-mediated apoptotic neuronal cell death.Cell Death Differ. 2022 May;29(5):1013-1027. doi: 10.1038/s41418-022-00982-5. Epub 2022 Mar 31. Cell Death Differ. 2022. PMID: 35361962 Free PMC article.
-
Tumorigenesis promotes Mdm4-S overexpression.Oncotarget. 2017 Apr 18;8(16):25837-25847. doi: 10.18632/oncotarget.15552. Oncotarget. 2017. PMID: 28460439 Free PMC article.
References
-
- Shvarts A, Bazuine M, Dekker P, Ramos YF, Steegenga WT, Merckx G, van Ham RC, van der Houven van Oordt W, van der Eb AJ, Jochemsen AG. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics. 1997;1:34–42. - PubMed
-
- Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, Helin K, Pelicci PG, Jochemsen AG, Marine JC. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol. Cell. Biol. 2004;24:5835–43. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous